WHO ICTRP trial
CD8+ CD38+ T cells in urine as a biomarker for transplant rejection
DRKS00035182 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00035182 |
|---|---|
| Public title | CD8+ CD38+ T cells in urine as a biomarker for transplant rejection |
| Scientific title | CD8+ CD38+ T cells in urine as a biomarker for transplant rejection - UTX-CD38 |
| Primary sponsor | Charité Universitätsmedizin Berlin |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | Z94.0;Kidney transplant status;Z94.0 |
| Interventions | Group 1: Validation of CD8+ CD38+ T cells in urine as a biomarker for transplant rejection. Included in the study are kidney transplant patients with an indication for graft biopsy due to suspected rejection. A urine sample (20-60ml) will… |
| Registration date | Jan 10, 2024 |
| Target size | 103 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: